FdaApplication
BLA 125293
Identifiers
- fda_app_no: BLA125293
Properties
| Property | Value |
|---|---|
| applicant_name | Horizon Therapeutics Ireland DAC |
| application_type | BLA |
| approval_date | 2010-09-14 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| KRYSTEXXA | PEGLOTICASE | 8MG/ML | INJECTABLE;INJECTION |
| KRYSTEXXA | — | 8MG/50ML (0.16MG/ML) | Injection |
2 products